Thus, indications that Sam68 may serve as a context-specific handle to curb hyperactive canonical Wnt/β-catenin activity and other CSC-supporting transcriptional networks, without disrupting healthy tissue integrity, is of particular interest for the development of next-generation therapeutics targeting cancer at its roots [24]. This evidence concerns the gene KHDRBS1 and cancer.